No Slide Title · Surg, 1999. Estee S, ... Solberg LI, Am J Prev Med, 2008. National Committee on...
Transcript of No Slide Title · Surg, 1999. Estee S, ... Solberg LI, Am J Prev Med, 2008. National Committee on...
©Treatment Research Institute, 2012
6/3/2015
Why Integrate Addiction Care
into Mainstream Medicine?
©Treatment Research Institute, 2013
A. Thomas McLellan Treatment Research Institute
Part I
Closing Thoughts
Substance use disorders” will soon be a
regular part of mainstream healthcare: 1. SUDs are too omnipresent, dangerous &
expensive in healthcare to be ignored
2. Market forces will accelerate integration
o Insurance benefits will bring new meds,
continuing care protocols & other tools
3. Mainstream healthcare can do this!
o Several protocols already fit into the system
Substance Use Among US Adults
Addiction ~ 23,000,000
Harmful – 40,000,000 Use
Little or No Use Little/No
Use
Very
Serious
Use
In Treatment ~ 2,300,000
1
1. Because it will improve
general medical care
2. Because it will save money
3. Because it’s the law.
1
1. Because it will improve
general medical care 2. Because it will save money
3. Because it’s the law.
Alcohol and drug use below “addiction” lead to:
misdiagnoses,
poor adherence to care,
interference with prescribed meds,
more physician time,
unnecessary medical testing,
poor outcomes
increased costs
Particularly in chronic illness.
Substance Use Impact on Healthcare
Vinson D, Ann Fam Med, 2004. Brown RL, J Amer Board Fam Prac, 2001. Humeniuk R, WHO, 2006. Manwell LB, J
Addict Dis, 1998. Longabaugh R. Alcohol Res Health, 1999. Healthiest Wisconsin 2010, WI DHFS, 2000. USPSTF,
Screening for Alcohol Misuse, 2004. National Quality Forum, National Voluntary Consensus Standards, 2006. Bernstein
J, Drug Alcohol Depend, 2005. Saunders B, Addiction, 1995. Stephens RS, J Consult Clin Psychol, 2000. Copeland J, J
Subst Abuse Treat 2001. Fleming MF, Med Care, 2000. Fleming MF, Alcohol Clin Exp Res, 2002. Gentilello LM, Ann
Surg, 1999. Estee S, Medicaid Cost Outcomes, Interim Report 4.61.1.2007.2, Washington State Department of Social
and Health Services. Yarnall KSH, Am J Public Health, 2003. Solberg LI, Am J Prev Med, 2008. National Committee on
Prevention Priorities, http://www.prevent.org/content/view/43/71/.
6
Systematic Reviews Diabetes:
– Howard et al. Ann Intern Med.
Hypertension:
– McFadden et al. Am J Hypertens.
Chronic pain:
– Martell et al. Ann Intern Med.
Breast cancer:
– Terry et al. Ann Epidemiol.
Sleep:
– Dinges et al. JAMA
Risk of Mortality & Drinks/Day
1.0
1.3
1.2
1.1
1.4
0.6
0.9
0.8
0.7
7 6 5 0 2 1
Drinks per Day
Ris
k o
f M
ort
alit
y
3 4
Di Castelnuovo et al. Arch. Int. Med. 2006;166(22):2437
What Are Low-Risk Drinking Limits?
Source: NIAAA, Rethinking Drinking: Alcohol and Your Health, 2009
Alcohol Use and Breast Cancer
Before Diagnosis – heavy drinkers
1.5 times chance of contracting
2.3 times chance w/BRCa2 gene
After Diagnosis – ANY Drinking
Increases risk of relapse
Interferes radio & chemo therapy
Nati
on
al In
sti
tute
on
Alc
oh
ol A
bu
se a
nd
Alc
oh
oli
sm
24
0
5
10
15
20
25
30
35
40
45
In College Not In College
Harmful Drinking Among Young People
10 or more drinks
Age 21-24
Age 18-20 Pe
rce
nt
Phillips, D. P. et al. 2008;168:1561-1566.
Alc/Drg Related
Fatal Errors
FME Death Rate
1983 - 2004
Potential impact on Safety: Fatal Medical Errors
• BU study of 87 patients with undisclosed opioid
use receiving primary care at BU Medical Center.
• 100% received at least one medication with a
significant drug-drug interaction
• Average number of significant interactions = 5
• 15 of 87 patients (17%) were treated by ED for
their interaction ($$$)
Drug-Drug Interactions – Safety Issues
Walley et al., J. Gen Internal Medicine, 24(9): 1007-11, 2009
Causes of Accidental Death
#1 Opioid Overdose
#2 Car Accidents
#3 Accidental Shooting
Source: CDC, 2013
Study 2 – Dunn et al, Annals 2009
• Prescription Drug Overdose Within a
Managed Care Environment
– Group Health study of overdose incidents and deaths
– 3,000 overdose reports in 2008
– Examined case histories and prescription records
• Death Rate of 11 / 100,000
– Predictors = Male; 30-50; Low SES;
MH/SA; OD history; Bz script; <10 days after script.
• 27% of reports had prior OD incident
Pain Society and State Guidelines for Pain Management
Model policy for the use of opioids in the treatment of pain.
http://www.fsmb.org/pdf/2004_grpol_Controlled_Substances.pdf
Gilson AM, Joranson DE, Maurer MA. Improving state pain policies: recent progress and continuing opportunities.
CA Cancer J Clin. 2007;57(6):341–353
1. Screening for & discussing substance use
2. Patient contract – Single doc & pharmacy
3. Patient & family education on safe storage
of medications
4. Urine Screening pre and during
prescribing (expanded test panel)
1
1. Because it will improve
general medical care
2. Because it will save money 3. Because it’s the law.
Substance Use Cost in Healthcare
Addiction ~ 23,000,000
“Harmful – 40,000,000
Use”
Little or No Use Little/No
Use
Very
Serious
Use
In Treatment ~ 2,300,000
$80 B
Yr
$40B
Yr
1
1. Because it will improve
general medical care
2. Because it will save money
3. Because it’s the law.
2009 Parity Act “MHPAEA”
“If” a health plan covers MH/SA
benefits should be comparable to
those of similar physical
illnesses”
2010 Affordable Care Act
• SA care is “Essential Service” • SA is firmly part of healthcare
• Funds full continuum of care • Prevent, BI, Meds, Spec Care
• Significant change in benefit • The nature/number of benefits
• The types of eligible providers
SUD Benefits Today
Addiction ~ 23,000,000
“Harmful – 40,000,000
Use”
Little or No Use Little/No
Use
Very
Serious
Use
In Treatment ~ 2,300,000
Addiction
• Detoxification – 100%
– Ambulatory – 80%
• Opioid Substitution Therapy – 50%
• Urine Drug Screen – 100%
– 7 per year
• Physician Visits – 100%
• Clinic Visits – 100%
• Home Health Visits – 100%
• Glucose Tests, Monitors, Supplies – 100%
• Insulin and 4 other Meds – 100%
• HgA1C, eye, foot exams 4x/yr – 100%
• Smoking Cessation – 100%
• Personal Care Visits – 100%
• Language Interpreter - Negotiated
SUD Benefits Under ACA
Addiction ~ 23,000,000
“Harmful – 40,000,000
Use”
Little or No Use Little/No
Use
Very
Serious
Use
In Treatment ~ 2,300,000
Benefit
for
“Substance
Use
Disorders”
• Physician Visits – 100%
– Screening, Brief Intervention, Assessment
– Evaluation and medication – Tele monitoring
• Clinic Visits – 100%
• Home Health Visits – 100%
– Family Counseling
• Alcohol and Drug Testing – 100%
• 4 Maintenance and Anti-Craving Meds – 100%
• Monitoring Tests (urine, saliva, other)
• Smoking Cessation – 100%
Pre-Diabetes
Clinically Managed Diabetes
Personally Managed Diabetes
Screening those at risk Motivational education
Behavioral Interventions Electronic Monitoring
Behavioral Interventions Medications
Family/Peer Support Close Monitoring
Electronic Monitoring Social/Environment Services
Family/Peer Supports
What is Needed?
SPECTRUM OF ILLNESS & CONTINUUM OF CARE:
Type 2 Diabetes
Clinically Managed
SUD
Harmful Use
Personally Managed
SUD
Substance Use Disorders
Clinically Managed Care Setting for Substance Use Disorders
1. Traditional Settings/Programs
a. Detox/Stabilization c. Partial Hospital
b. Residential d. IOP/Outpatient
2. Setting placement/transition determined by:
a. Severity, duration, complexity of illness
b. Availability of social supports
Stage 2 – Clinical Management
Goals
Methods
1. Establish/Maintain reductions in substance use 2. Improve general health and social function 3. Educate patient/Family to understand, monitor and
manage substance use problem 4. Engage Patient/Family/Support network into Stage 3 care
1. Individual, Family and Group Behavioral therapies 2. Rational Medication Regimen
a. Anti-craving medications (maintenance?) b. Appropriate meds for psychiatric and physical illness
3. Electronic and personal monitoring – a. Weekly for 1 month – Bi-Weekly for 3 months b. Monthly for six months
Outcomes &
Indicators
1. Elimination or Significant Reduction of Use as Indicated by urine drug screens during monitoring
2. Active engagement in Stage 3 Care
1. Patient acknowledges “relapse” 2. Patient agrees to more intensive monitoring and/or 3. Patient agrees to intensify care
OR
1. Serious relapse or overdose incident 2. Hospital, ER or Residential Treatment
Required
NOTE Stage 2 an be done in Primary, Specialty OPT or
Specialty Residential Settings
Greater severity/complexity/chronicity increases: * need for frequent monitoring and medication
* Need for specialty care, and * Need for protective setting
But Not
Substance Use Among US Adults
Addiction ~ 23,000,000
“Harmful – 40,000,000
Use”
Little or No Use Little/No
Use
Very
Serious
Use
In Treatment ~ 2,300,000
Prevention
Early
Intervention
Treatment
Closing Thoughts
Substance use disorders” will soon be a
regular part of mainstream healthcare: 1. SUDs are too common, dangerous & expensive
in healthcare to be ignored
2. Public understanding that addiction is an
illness not a sin
3. Mainstream healthcare can do this!
o Chronic Care Management protocols are appropriate
©Treatment Research Institute, 2012
6/3/2015
Why Should we Integrate Care for
Substance Use Disorders into
Mainstream Medicine?
©Treatment Research Institute, 2013
A. Thomas McLellan Treatment Research Institute
What will it take to Integrate
Part II
Background
Prominent University Medical Center in Philadelphia
• CEO of Healthcare System – “JCAH wants this – whatever it is – I want it in the whole system.
Start with whichever clinic raises their hand.”
• Cancer center administrator raises his hand –
currying favor
41
Meeting 1 With Cancer Staff
• With Docs - ready to discuss procedures
• Go through slides – NO Questions
• Immediate Result
• Letter to Dean – “ Why do we have to do
Psychiatry’s work….trolling for addicts is not part of our mission”
42
Meeting 2 With Cancer Staff
• Bring in the research
• Alcohol is significant predictor of susceptibility to BC
• Alcohol at any dose accelerates tumor growth
• BI reduces alcohol use among non-dependent drinkers
• BI is paid for
• Re-set Expectations
• NOT here FOR a favor – here to DO a favor
• If not good for cancer treatment – we leave – no problem
43
Meeting 3 With Cancer Staff
• Surprised but convinced by the research
• New concerns – fit and clinical value in work setting
• Training and Time (Rotations every 12 weeks)
• Workflow - Who, When, How
• What exactly to say – What exactly to do
• Patient Neg Reactions – “Probing into their
lifestyle”
• Electronic Health Record (EHR)
44
45
Active problem of patient is entered into the patient’s problem list (this example
is breast cancer)
SBI and EPIC
EARLY Results
• No Patient Problems/Complaints
• No Intrusion into Workflow/Routine
• No “Alcoholism” – 10% drink above thresh.
• Cancer Center gets CQI credit/prize
– CQI adds SBI as a “performance measure”
• SBI is now part of regional cancer training
• Reduced drinking, better cancer care ???
46
Background
• Suburban NYC School System
• MANY Drug Probs
• School Superintendant – “We need help,
teachers can’t teach, getting dangerous …”
• Other tiny little issues
• School is broke – no money for new interventions
• Teacher’s Union will not allow teachers to do more
• School Board is furious w/Superintendant (Property Values)
48
Issues
• What MIGHT work?
• SBI
• Who should do health screening – can they pay?
• Education – NO – Hell NO – Absolutely NO
• Health Department – Yes, part of recurring budget
• But ONLY in “Registered Health Clinic”
• Who should do the BI and RT?
• SA Treatment program – but only if it is reimbursed
• Why would a kid self disclose substance use?
• PERHAPS if it were engaging, useful, confidential 49
Solutions Round 1 • Create a “Health Clinic” in the School –
• Get architect and builder and inspector
• Get license and billing authorization - Phoenix House
• Get agreement that this is Prevention
• No need for Parent consent
• No record of “substance abuse treatment”
• Credit – NYC DoH (OASAS) & DoE
50
Solutions Round 2 • Create an engaging, anonymous screen
• Begin with CRAFFT – NYC regulations
• Use computer – private, multi-language, audio
• Tailored Software
• Anonymous & Confidential
• Personalized Feedback (BAC)
• Provide Tailored Guidance to Counselor for BI
• Develop detailed clinical protocol – manual – billing
Solutions Round 3 • Create tailored BI sessions and decision criteria
• 1 - Kids with no problems
• 2 – Kids with emerging use – to problem use
• 3 – Kids with significant problems
• Fundamentally different – Parent Involvement
• Develop confidentiality protections
• Develop billing and administrative procedures
Alpha Testing – 2 months
• Insurance problems
• Ultimately need parental consent - insurance
• School scheduling problems – too much time out
• Screen only during non-academic classes
• Computer problems
• Better, faster forms generation
• Training problems
• Two counselors could not learn MI
53
Beta Testing – 12 Months
• No teacher, admin or parent problems – BUT
absolutely NO teacher or parent involvement
• Screened 480 kids – 16 weeks
• Over-reporting of substance use (53%)
• 42 % students received 2 MI sessions
• 4 students & 9 parents referred to treatment
• Financially viable at 2 counselors @ 5-6 per day in
schools of 500+
• Now want depression, bullying, diabetes screens 54